SOD3 Antibody

What is SOD3 and why is it important in biological research?

SOD3, also known as extracellular superoxide dismutase (EC-SOD), plays a crucial role in protecting tissues from oxidative stress by catalyzing the dismutation of superoxide radicals into hydrogen peroxide and oxygen, thereby mitigating cellular damage caused by reactive oxygen species (ROS) . SOD3 is predominantly located in extracellular fluids such as lymph, plasma, and synovial fluid, which allows it to exert protective effects throughout the body . This enzyme is particularly important in various degenerative diseases, including Alzheimer's and Parkinson's disease, where oxidative stress is a contributing factor . SOD3's ability to bind copper and zinc is essential for its enzymatic activity, highlighting the importance of metal ion availability in maintaining function and cellular health .

What are the key differences between SOD3 antibody clones, and how should researchers select the appropriate one?

Researchers should consider several factors when selecting SOD3 antibody clones:

• Antibody isotype: For example, SOD-3 Antibody (G-11) is a mouse monoclonal IgG1 kappa light chain antibody , while SOD-3 Antibody (A-11) is a mouse monoclonal IgG2a kappa light chain antibody . The isotype can affect experimental outcomes in certain applications.

• Species reactivity: Both G-11 and A-11 clones detect SOD-3 in mouse, rat, and human samples , but researchers should verify reactivity with their specific model organism.

• Application compatibility: While both antibodies work for western blotting, immunoprecipitation, immunofluorescence, and ELISA , specific clones may perform better in certain applications based on epitope recognition and binding affinity.

• Conjugation options: Both antibodies are available in non-conjugated forms and with various conjugates (agarose, HRP, PE, FITC, and Alexa Fluor®) , allowing selection based on detection method requirements.

How should researchers store and handle SOD3 antibodies to maintain optimal activity?

To maintain optimal antibody activity, researchers should follow these guidelines:

• Storage conditions:

  • Store unopened antibodies at -20 to -70°C for up to 12 months from the date of receipt

  • After reconstitution, store at 2 to 8°C under sterile conditions for up to 1 month

  • For long-term storage after reconstitution, aliquot and store at -20 to -70°C for up to 6 months

• Handling practices:

  • Use a manual defrost freezer and avoid repeated freeze-thaw cycles

  • Reconstitute lyophilized antibodies according to manufacturer specifications

  • Work with antibodies on ice when possible

  • Centrifuge briefly before opening vials to collect all material

  • Use sterile techniques when handling reconstituted antibodies

• Quality control:

  • Document lot numbers and expiration dates

  • Periodically validate antibody activity with positive controls

  • Monitor for signs of degradation (precipitation, loss of activity)

What are the optimal conditions for using SOD3 antibodies in Western blot applications?

For optimal Western blot results with SOD3 antibodies, researchers should consider:

• Sample preparation:

  • Use PVDF membrane for protein transfer

  • Run under reducing conditions

  • Include appropriate tissue positive controls such as mouse lung and kidney

• Antibody concentrations:

  • Use primary SOD3 antibody at approximately 1 μg/mL concentration

  • Follow with appropriate HRP-conjugated secondary antibody (e.g., Anti-Goat IgG Secondary Antibody, catalog # HAF017)

• Expected results:

  • SOD3/EC-SOD should be detected at approximately 30-40 kDa

  • The 30 kDa band typically appears in mouse lung tissue samples

  • A specific 40 kDa band can be detected in mouse aorta lysates using Simple Western technology

• Controls:

  • Include recombinant mouse SOD1, SOD2, and SOD3 (5 ng/lane) to verify antibody specificity

  • Use multiple tissue samples with known SOD3 expression patterns (lung tissue typically shows stronger expression than kidney)

How can researchers optimize immunofluorescence protocols for SOD3 localization studies?

To achieve optimal immunofluorescence results for SOD3 localization:

• Fixation and permeabilization:

  • Use paraformaldehyde fixation (4%, 10-15 minutes) to preserve protein epitopes

  • Select permeabilization reagents appropriate for extracellular proteins (SOD3 is extracellular)

  • Consider gentler detergents (0.1-0.2% Triton X-100) to maintain extracellular matrix integrity

• Antibody selection and concentration:

  • Choose fluorophore-conjugated antibodies (FITC, PE, or Alexa Fluor® conjugates) for direct detection

  • For indirect detection, use unconjugated primary antibody followed by fluorophore-conjugated secondary antibody

  • Titrate antibody concentrations to determine optimal signal-to-noise ratio

• Controls and counterstaining:

  • Include isotype controls to assess non-specific binding

  • Use DAPI or other nuclear counterstains for cellular context

  • Include positive control tissues with known SOD3 expression patterns

• Microscopy considerations:

  • Use confocal microscopy for precise localization within tissue architecture

  • Capture Z-stacks to analyze extracellular distribution in three dimensions

  • Consider super-resolution techniques for detailed extracellular matrix studies

What validation steps should researchers take to confirm SOD3 antibody specificity?

Thorough validation of SOD3 antibody specificity requires:

• Positive and negative controls:

  • Use tissue lysates with known SOD3 expression (e.g., mouse lung as positive; other tissues with lower expression as comparative controls)

  • Include recombinant SOD3 protein as a positive control

  • Test SOD3-deficient samples (knockout or knockdown) when available

• Cross-reactivity assessment:

  • Test against recombinant SOD1 and SOD2 proteins to confirm absence of cross-reactivity

  • Run multiple antibody clones targeting different epitopes to confirm consistent detection patterns

• Technical validation:

  • Compare detection across multiple techniques (Western blot, ELISA, immunofluorescence)

  • Verify protein size corresponds to expected molecular weight (approximately 30-40 kDa)

  • Confirm detection in multiple relevant species if performing comparative studies

• Documentation:

  • Record complete validation data including antibody catalog numbers, lot numbers, and experimental conditions

  • Include validation controls in publications and reports

How can SOD3 antibodies be used to investigate the role of SOD3 in parasite infections?

Recent research has revealed that SOD3 levels are significantly elevated in both Plasmodium falciparum malaria patients and mice infected with four parasite species . SOD3 antibodies can be instrumental in studying this phenomenon:

• Expression analysis methodologies:

  • Western blotting to quantify SOD3 protein levels in infected versus uninfected tissues

  • Immunohistochemistry to map SOD3 distribution in infected tissues

  • ELISA to measure circulating SOD3 levels in patient or animal model serum

• Functional studies:

  • Immunofluorescence co-localization with immune cell markers to identify SOD3-producing cells

  • Immunoprecipitation to identify SOD3 binding partners during infection

  • Combined with flow cytometry to examine SOD3 binding to T cells and effects on cytokine production

• Mechanistic investigations:

  • Monitor SOD3 levels in relation to parasitemia and disease progression

  • Compare wild-type, SOD3-deficient, and SOD3-overexpressing models to assess impact on parasite clearance

  • Investigate how SOD3 suppresses IL-2 expression and interferon-gamma responses crucial for parasite clearance

• Therapeutic potential assessment:

  • Use antibodies to neutralize or detect SOD3 in therapeutic intervention studies

  • Monitor changes in SOD3 levels following antiparasitic treatments

What approaches can researchers use to study the relationship between SOD3 and oxidative stress in degenerative diseases?

To investigate SOD3's role in degenerative diseases characterized by oxidative stress:

• Expression pattern analysis:

  • Use Western blotting and immunohistochemistry to map SOD3 distribution in affected tissues

  • Compare SOD3 levels across disease stages using quantitative methods

  • Correlate SOD3 expression with markers of disease progression

• Functional assessments:

  • Combine SOD3 antibody detection with oxidative stress markers (8-OHdG, 4-HNE, etc.)

  • Co-localization studies with disease-specific markers (e.g., amyloid plaques in Alzheimer's)

  • Examine SOD3 activity in relation to ROS levels and oxidative damage

• Mechanistic studies:

  • Investigate SOD3 binding to extracellular matrix components using co-immunoprecipitation

  • Assess SOD3's interaction with other antioxidant systems

  • Examine the relationship between metal ion availability (copper/zinc) and SOD3 function

• Intervention studies:

  • Monitor changes in SOD3 expression following antioxidant therapy

  • Evaluate effects of SOD3 modulation on disease progression

  • Assess potential of SOD3 as a biomarker for treatment response

How can researchers address contradictory findings regarding SOD3 expression or function?

When confronted with contradictory SOD3 data, researchers should:

• Evaluate methodological differences:

  • Compare antibody clones and their epitope recognition sites

  • Assess differences in experimental conditions (reducing vs. non-reducing, sample preparation)

  • Consider detection method sensitivity and specificity

  • Examine tissue preservation and processing techniques

• Consider biological variables:

  • Species differences in SOD3 structure, function, or regulation

  • Tissue-specific expression patterns and microenvironmental factors

  • Disease stage and severity influences on SOD3 expression

  • Genetic background effects on SOD3 expression and activity

• Design resolution experiments:

  • Use multiple antibody clones targeting different epitopes

  • Apply complementary techniques (protein analysis, mRNA expression, activity assays)

  • Include appropriate controls for each experimental system

  • Increase sample size and biological replicates to improve statistical power

• Data integration framework:

  Consideration	Approach	Expected Outcome
  Antibody factors	Compare multiple validated antibodies	Identify epitope-specific detection differences
  Method factors	Apply orthogonal techniques	Distinguish technical artifacts from biological variation
  Biological context	Stratify by tissue type, disease stage, etc.	Clarify context-dependent SOD3 regulation
  Functional validation	Correlate expression with activity	Resolve discrepancies between presence and function

What are common technical issues when using SOD3 antibodies and how can they be resolved?

Researchers frequently encounter these challenges with SOD3 antibodies:

• Weak or absent signal in Western blotting:

  • Ensure reducing conditions are used for optimal epitope exposure

  • Increase antibody concentration (reference concentrations: 1 μg/mL for primary antibody)

  • Verify sample contains adequate SOD3 by including positive control tissues (mouse lung)

  • Check for proper transfer by confirming protein transfer with Ponceau S staining

  • Consider using HRP-conjugated antibody for direct detection

• Multiple bands or non-specific binding:

  • Optimize blocking conditions (5% non-fat milk or BSA)

  • Increase washing stringency and duration

  • Validate with recombinant SOD1, SOD2, and SOD3 to confirm specificity

  • Consider more specific monoclonal antibodies (G-11 or A-11 clones)

  • Verify sample preparation quality (use fresh samples, appropriate protease inhibitors)

• Detection issues in immunohistochemistry/immunofluorescence:

  • Optimize fixation and permeabilization for extracellular proteins

  • Perform antigen retrieval if necessary

  • Adjust antibody concentration based on tissue type

  • Reduce autofluorescence with appropriate quenching methods

  • Use directly conjugated antibodies to reduce background

• Inconsistent immunoprecipitation results:

  • Consider using agarose-conjugated antibodies for direct pulldown

  • Optimize lysis conditions to preserve protein-protein interactions

  • Pre-clear lysates to reduce non-specific binding

  • Increase antibody-to-lysate ratio for low-abundance proteins

  • Verify results with multiple antibody clones

What methodological approaches can improve SOD3 detection in samples with low expression levels?

For improved detection of low-abundance SOD3:

• Enhanced Western blot sensitivity:

  • Use HRP-conjugated primary antibodies for direct detection

  • Apply signal enhancement systems (enhanced chemiluminescence)

  • Consider longer exposure times or more sensitive detection systems

  • Use gradient gels (5-20% SDS-PAGE) for optimal protein separation

  • Concentrate proteins by immunoprecipitation before Western blotting

• Amplification strategies for immunohistochemistry:

  • Implement tyramide signal amplification (TSA)

  • Use biotin-streptavidin amplification systems

  • Optimize antigen retrieval techniques for improved epitope exposure

  • Consider multiplex staining to correlate with other markers

• Sample enrichment approaches:

  • Focus on tissues with known higher SOD3 expression (lung, kidney, aorta)

  • Use subcellular fractionation to isolate extracellular components

  • Consider concentration methods for fluid samples (ultrafiltration, precipitation)

• Alternative detection strategies:

  • Employ more sensitive ELISA detection systems

  • Consider proximity ligation assay (PLA) for in situ detection

  • Use SOD3 activity assays in parallel with antibody-based detection

How should researchers quantify and statistically analyze SOD3 levels across experimental conditions?

For robust quantification and statistical analysis of SOD3 levels:

• Western blot quantification:

  • Use appropriate loading controls (β-actin, GAPDH for total protein; extracellular markers for SOD3)

  • Apply densitometry software with background subtraction

  • Generate standard curves using recombinant SOD3 protein

  • Express results as relative density normalized to controls

• Immunohistochemistry/immunofluorescence quantification:

  • Use computer-aided image analysis with consistent thresholds

  • Quantify signal intensity and distribution patterns

  • Employ region of interest (ROI) analysis for spatial comparisons

  • Include negative and positive control tissues in each analysis

• ELISA and other quantitative assays:

  • Generate standard curves with recombinant SOD3

  • Run samples in technical triplicates

  • Include quality control samples across multiple plates/runs

  • Calculate coefficients of variation to assess precision

• Statistical analysis framework:

  Experimental Design	Recommended Statistical Test	Sample Size Considerations
  Two groups comparison	Student's t-test or Mann-Whitney U	Minimum n=5 per group, power analysis recommended
  Multiple group comparison	ANOVA with appropriate post-hoc tests	Minimum n=5 per group, increase for small effect sizes
  Correlation analysis	Pearson's or Spearman's correlation	Minimum n=10, more for complex relationships
  Time course studies	Repeated measures ANOVA	Account for subject attrition in planning
  Multi-factor experiments	Two-way or multi-way ANOVA	Increase sample size for interaction analysis

• Reporting standards:

  • Present both raw data and normalized values

  • Include measures of dispersion (standard deviation, standard error)

  • Report exact p-values rather than significance thresholds

  • Provide clear descriptions of normalization methods and statistical tests

How can SOD3 antibodies be used to investigate the immunomodulatory functions of SOD3?

Recent discoveries about SOD3's immunomodulatory functions open new research avenues:

• Immune cell interaction studies:

  • Use immunofluorescence to examine SOD3 binding to T cells

  • Investigate SOD3 secretion by activated neutrophils

  • Assess how SOD3 affects interleukin-2 expression and interferon-gamma responses

• Parasite infection models:

  • Compare SOD3-deficient, wild-type, and SOD3-overexpressing models for immune response differences

  • Correlate SOD3 levels with parasitemia and survival outcomes

  • Examine tissue-specific immune responses using immunohistochemistry

• Mechanistic investigations:

  • Combine SOD3 antibody detection with cytokine profiling

  • Investigate signaling pathways affected by SOD3 binding to immune cells

  • Examine SOD3's role in the balance between pro- and anti-inflammatory responses

• Therapeutic implications:

  • Explore SOD3 modulation as a potential immunotherapy approach

  • Investigate SOD3 as a biomarker for immune response to infections

  • Study SOD3 manipulation as a strategy for enhancing parasite clearance

What novel applications of SOD3 antibodies are emerging in cardiovascular research?

Emerging applications of SOD3 antibodies in cardiovascular research include:

• Vascular homeostasis studies:

  • Immunolocalization of SOD3 in vascular tissues like aorta

  • Investigation of SOD3's role in protecting against atherosclerosis

  • Examination of SOD3 distribution in relation to vascular lesions

• Oxidative stress monitoring:

  • Correlation of SOD3 levels with markers of vascular oxidative damage

  • Temporal analysis of SOD3 expression during progression of vascular diseases

  • Assessment of SOD3 activity in relation to other antioxidant systems

• Therapeutic intervention assessment:

  • Monitoring changes in SOD3 expression following cardiovascular treatments

  • Evaluation of SOD3-targeted therapies in vascular disease models

  • Investigation of SOD3 as a biomarker for treatment response

• Advanced imaging applications:

  • Development of antibody-based probes for non-invasive imaging of vascular SOD3

  • Combined SOD3 detection with markers of vascular inflammation

  • Three-dimensional reconstruction of SOD3 distribution in vessel walls

How might SOD3 antibodies contribute to understanding the extracellular matrix-SOD3 relationship in tissue remodeling?

SOD3 antibodies can provide insights into extracellular matrix interactions:

• Localization studies:

  • Co-immunofluorescence with extracellular matrix components

  • Investigation of SOD3 binding to heparin sulfate proteoglycans

  • Examination of SOD3 distribution patterns in the matrix during remodeling

• Mechanistic investigations:

  • Immunoprecipitation to identify SOD3 binding partners in the extracellular matrix

  • Assessment of how matrix composition affects SOD3 distribution and activity

  • Investigation of SOD3's role in protecting matrix components from oxidative damage

• Tissue remodeling analysis:

  • Monitoring SOD3 expression during wound healing and fibrosis

  • Correlation of SOD3 levels with matrix metalloproteinase activity

  • Examination of SOD3's role in regulating matrix turnover and deposition

• Methodological approaches:

  • Use of decellularized matrices to study SOD3-matrix interactions

  • Application of tissue engineering models to manipulate SOD3-matrix relationships

  • Development of 3D culture systems to study SOD3 function in complex microenvironments